Clinical Trials on Paralisia Bulbar Progressiva
Total 0 results
Nothing found
Sponsors and Collaborators
- ImproveCareNow (ICN)
- Mononuclear Therapeutics Ltd.
- North Karelia Hospital District
- Maria Lendorf
- Nestor Soler Porcar, MD, PhD
- Veeda Oncology
- Neuregenix
- Grand Challenges Canada
- Bjørgene Omsorgssenter, Haugesund
- Prestige Biopharma Limited
- Equipe MiMes
- Bruce County Paramedic Service
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Chengdu Nuoen Biotechnologies, Inc.
- Centro di Procreazione Assistita Demetra
- InflaRx GmbH
- Women and children's hospital of Jiaxing university
- Reina Sofia University Hospital
- AIDS Council of New South Wales
- BayCare Health System
- View Full List
Medical Conditions
- Ewing's Family Tumors
- Gullian Barre Syndrome
- Fracture Dislocation of Cervical Spine
- Childhood Langerhans Cell Histiocytosis
- Chlamydophila Infections
- Closure; Foramen Ovale
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Painless Hysteroscopy
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Spine Surgeries
- Predictors of Atrial Fibrillation Recurrences
- Endocarditis Infective
- Tay-Sachs Disease Ganglioside
- Fetus or Neonate Affected by External Version Before Labor
- Epidemic Hemorrhagic Fever
- Pulmonary Adenocarcinoma
- Psoriasis, Arthritic
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Multisystem Proteinopathy
- Skull Base Neoplasms
- View Full List
Drug Interventions
- Redifferentiation with retinoid acid
- Qingkailing injection 40 ml
- Estradiol+Drospirenone
- Adriamycin
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Semapimod
- Azelastine hydrochloride (BAYR9258)
- Glimepiride
- High dose pantoprazole infusion
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Esomeprazole 40mg before
- Palliative care group first-line scheme
- Adapalene Gel 0.3%
- Vehicle
- Chemotherapeutic Agent
- Neihulizumab
- EFV +TVA
- Cereport
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- View Full List
CROs by country
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Estonia
- Contract Research Organizations in Hungary
- Contract Research Organizations in Iran
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Moldova
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Zambia
- Contract Research Organizations in Zimbabwe
- CRO list by country